Peter B. Bitterman

Peter B. Bitterman

Auto-generated profile, based on publicly available information

Peter B. Bitterman

Department of Medicine, University of Minnesota, Minneapolis, Minnesota, United States

Research Focus & Metrics

Academic Career Length

47Years (1980-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
TZTao Zu
Tao Zu
BGBrian Gibbens
Brian Gibbens
NDNoelle S. Doty
Noelle S. Doty
MGMário Gomes-Pereira
Mário Gomes-Pereira
AHAline Huguet
Aline Huguet
LRLaura P. W. Ranum
Laura P. W. Ranum
Trinucleotide expansions cause disease by both protein- and RNA-mediated mechanisms. Unexpectedly, we discovered that CAG expansion constructs express homopolymeric polyglutamine, polyalanine, and polyserine proteins in the absence of an ATG start codon. This repeat-associated non-ATG translation (RAN translation) occurs across long, hairpin-forming repeats in transfected cells or when expansion constructs are integrated into the genome in lentiviral-transduced cells and brains. Additionally, we show that RAN translation across human spinocerebellar ataxia type 8 (SCA8) and myotonic dystrophy type 1 (DM1) CAG expansion transcripts results in the accumulation of SCA8 polyalanine and DM1 polyglutamine expansion proteins in previously established SCA8 and DM1 mouse models and human tissue. These results have implications for understanding fundamental mechanisms of gene expression. Moreover, these toxic, unexpected, homopolymeric proteins now should be considered in pathogenic models of microsatellite disorders.

2 January 2018 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
JHJeremy Herrera
Jeremy Herrera
CHCraig A. Henke
Craig A. Henke
PBPeter B. Bitterman
Peter B. Bitterman
The extracellular matrix (ECM) is dynamically tuned to optimize physiological function. Its major properties, including composition and mechanics, profoundly influence cell biology. Cell-ECM interactions operate through an integrated set of sensor and effector circuits that use several classes of receptors and signal transduction pathways. At the single-cell level, the ECM governs differentiation, metabolism, motility, orientation, proliferation, and survival. At the cell population level, the ECM provides higher-order guidance that is essential for physiological function. When pathological changes in the ECM lead to impairment of organ function, we use the term “fibrosis.” In this Review, we differentiate fibrosis initiation from progression and focus primarily on progressive lung fibrosis impairing organ function. We present a working model to explain how the altered ECM is not only a consequence but also a driver of fibrosis. Additionally, we advance the concept that fibrosis progression occurs in a fibrogenic niche that is composed of a fibrogenic ECM that nurtures fibrogenic mesenchymal progenitor cells and their fibrogenic progeny.

3 March 2014 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
MPMatthew W. Parker
Matthew W. Parker
DRDaniel Rossi
Daniel Rossi
MPMark Peterson
Mark Peterson
KSKaren Smith
Karen Smith
KSKristina Sikström
Kristina Sikström
PBPeter B. Bitterman
Peter B. Bitterman
Pathological remodeling of the extracellular matrix (ECM) by fibroblasts leads to organ failure. Development of idiopathic pulmonary fibrosis (IPF) is characterized by a progressive fibrotic scarring in the lung that ultimately leads to asphyxiation; however, the cascade of events that promote IPF are not well defined. Here, we examined how the interplay between the ECM and fibroblasts affects both the transcriptome and translatome by culturing primary fibroblasts generated from IPF patient lung tissue or nonfibrotic lung tissue on decellularized lung ECM from either IPF or control patients. Surprisingly, the origin of the ECM had a greater impact on gene expression than did cell origin, and differences in translational control were more prominent than alterations in transcriptional regulation. Strikingly, genes that were translationally activated by IPF-derived ECM were enriched for those encoding ECM proteins detected in IPF tissue. We determined that genes encoding IPF-associated ECM proteins are targets for miR-29, which was downregulated in fibroblasts grown on IPF-derived ECM, and baseline expression of ECM targets could be restored by overexpression of miR-29. Our data support a model in which fibroblasts are activated to pathologically remodel the ECM in IPF via a positive feedback loop between fibroblasts and aberrant ECM. Interrupting this loop may be a strategy for IPF treatment.

19 January 1984 in New England Journal of Medicine
Verified
Journal Article
Closed access
RCRonald G. Crystal
Ronald G. Crystal
PBPeter B. Bitterman
Peter B. Bitterman
SRStephen I. Rennard
Stephen I. Rennard
AHAllan J. Hance
Allan J. Hance
BKBrendan A. Keogh
Brendan A. Keogh
THE interstitial lung diseases are a heterogeneous group of disorders of the lower respiratory tract characterized by derangements of the alveolar walls and loss of functional alveolar capillary units.1 2 3 More than 100 agents are known to cause interstitial disease, but in two thirds of all cases, no cause can be identified.3 This group, commonly referred to as interstitial lung diseases of unknown cause, is responsible for more than 10,000 hospital admissions in the United States each year and has a prevalence of 5 to 10 cases per 100,000 population.3 The list of interstitial lung diseases of unknown cause includes 35 . . .

1 January 1986 in Nature
Verified
Journal Article
Closed access
PDF file
YMYves Martinet
Yves Martinet
PBPeter B. Bitterman
Peter B. Bitterman
JMJean-Francois Mornex
Jean-Francois Mornex
GGGary R. Grotendorst
Gary R. Grotendorst
GMGeorge R. Martin
George R. Martin
RCRonald G. Crystal
Ronald G. Crystal

1 June 2004 in Cancer Cell
Verified
Journal Article
Closed access
SASvetlana Avdulov
Svetlana Avdulov
SLShunan Li
Shunan Li
VMVan Michalek
Van Michalek
DBDavid Burrichter
David Burrichter
MPMark Peterson
Mark Peterson
VPVitaly A Polunovsky
Vitaly A Polunovsky